A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression Disorder比较劳拉西泮或IVIg与无治疗对唐氏综合征退行性障碍的疗效研究Neurology and TherapyIF4.82026-03-080OAAI
Evidence of blood-brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression DisorderANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGYIF3.92025-02-250OA
Safety and Tolerability of Home Infusions in Down Syndrome Regression DisorderCLINICAL THERAPEUTICSIF3.62025-02-010PRE
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorderSCIENTIFIC REPORTSIF3.92024-12-280OAAI
Down Syndrome and Autoimmune Disease唐氏综合征与自身免疫性疾病CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGYIF11.32024-06-241OAAI
Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorderANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGYIF3.92024-02-204OA
The Impact of Neuroimmunologic Disease and Developing Nervous SystemPEDIATRIC NEUROLOGYIF2.12023-11-011PRE
Hypovitaminosis D in persons with Down syndrome and autism spectrum disorderJOURNAL OF NEURODEVELOPMENTAL DISORDERSIF42023-10-251OAAI
Alternative Diagnoses in the Work Up of Down Syndrome Regression DisorderJOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERSIF2.82023-08-160PRE
Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorderTRANSLATIONAL PSYCHIATRYIF6.22023-08-088OAAI
Evidence of Neuroinflammation and Immunotherapy Responsiveness in Individuals with Down Syndrome Regression DisorderNEUROLOGYIF8.52023-04-250PRE
Child Neurology: Neurodegenerative Encephalomyelopathy Associated With ACOX1 Gain-of-Function Variation Partially Responsive to ImmunotherapyNEUROLOGYIF8.52022-08-236OA
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder唐氏综合症回归障碍个体的神经炎症和免疫治疗反应性的证据JOURNAL OF NEURODEVELOPMENTAL DISORDERSIF42022-06-0327OAAI